Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Geisslinger

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|May 21, 2010
Bedside-to-bench pharmacology: a complementary concept to translational pharmacologyJ Lötsch, G Geisslinger
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Fundamental principles of clinical trials]C Skarke, G Geisslinger
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1993
[Advantages and disadvantages of anesthesia induction with midazolam and S-ketamine in comparison with barbiturates]W Hering, G Geisslinger
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2014
[Not Available]H Schmidt, G Geisslinger
Schmerz (Berlin, Germany)|January 26, 2002
[Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability]H Schmidt, G Geisslinger
Der Orthopade|December 5, 2003
[Clinical pharmacology of the selective COX-2 inhibitors]M Burian, G Geisslinger
MMW Fortschritte Der Medizin|April 29, 2000
[Pain management in general practice. Therapy with nonsteroidal anti-inflammatory drugs]I Tegeder, G Geisslinger
Clinical Pharmacokinetics|August 21, 2001
Morphine-6-glucuronide: an analgesic of the future?J Lötsch, G Geisslinger
The Pharmacogenomics Journal|January 18, 2006
Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteersJ Lötsch, G Geisslinger
Journal of Clinical Pharmacology|June 1, 1996
New insights into the site and mode of antinociceptive action of flurbiprofen enantiomersG Geisslinger, H G Schaible
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|May 21, 2010
Bedside-to-bench pharmacology: a complementary concept to translational pharmacologyJ Lötsch, G Geisslinger
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2005
[Fundamental principles of clinical trials]C Skarke, G Geisslinger
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1993
[Advantages and disadvantages of anesthesia induction with midazolam and S-ketamine in comparison with barbiturates]W Hering, G Geisslinger
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|April 15, 2014
[Not Available]H Schmidt, G Geisslinger
Schmerz (Berlin, Germany)|January 26, 2002
[Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability]H Schmidt, G Geisslinger
Der Orthopade|December 5, 2003
[Clinical pharmacology of the selective COX-2 inhibitors]M Burian, G Geisslinger
MMW Fortschritte Der Medizin|April 29, 2000
[Pain management in general practice. Therapy with nonsteroidal anti-inflammatory drugs]I Tegeder, G Geisslinger
Clinical Pharmacokinetics|August 21, 2001
Morphine-6-glucuronide: an analgesic of the future?J Lötsch, G Geisslinger
The Pharmacogenomics Journal|January 18, 2006
Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteersJ Lötsch, G Geisslinger
Journal of Clinical Pharmacology|June 1, 1996
New insights into the site and mode of antinociceptive action of flurbiprofen enantiomersG Geisslinger, H G Schaible
Pageof 19